RYAN UNA S — SEC insider filings
SEC reporting owner CIK 1255349. 13 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2021-06-17 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RenovoRx, Inc. (RNXT) | Director | 8 | — | — | 11 |
| Quince Therapeutics, Inc. (QNCX) | Director | 5 | — | — | 5 |
Insider filings — RYAN UNA S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 55,924 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | RenovoRx, Inc. (RNXT) | Other (J): 47,789 @ $4.19 · Other (J): 6,332 @ $3.95 · Other (J): 26,838 @ $0.93 · Other (J): 16,206 @ $1.62 | EDGAR |
| 2025-10-02 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 47,640 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 25,099 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2023-10-02 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 25,099 (derivative) @ $0 | EDGAR |
| 2023-05-26 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2022-10-04 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 25,099 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Cortexyme, Inc. (CRTX) | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2022-03-14 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 4,582 (derivative) @ $0 | EDGAR |
| 2021-10-05 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 11,154 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Cortexyme, Inc. (CRTX) | Grant/award (A): 11,029 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-06-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1255349 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs